Business Wire

AccelStor Debuting NeoSapphire All-Flash Array Series at GDPR in the Public Sector Conference

Jaa

AccelStor, the software-defined all-flash array provider, will be demonstrating its NeoSapphire all-flash array products at the “GDPR in the Public Sector” Conference. NeoSapphire All-Flash arrays offer a worry-free and GDPR compliant storage solution. AccelStor’s software-defined storage platform provides both powerful performance and strong data protection capabilities assisting customers with heavy-load requirements to construct a secured IT infrastructure and ensure they are GDPR compliant. The NeoSapphire All-Flash Array will be on display at Old Trafford Stadium in Manchester, UK on November 8, 2017.

This press release features multimedia. View the full release here: http://www.businesswire.com/news/home/20171101005006/en/

NeoSapphire series provides a worry-free all-flash storage solution that is fully GDPR compliant in  ...

NeoSapphire series provides a worry-free all-flash storage solution that is fully GDPR compliant in terms of affected systems and software capabilities. (Photo: Business Wire)

The EU General Data Protection Regulations (GDPR) will take effect in May 2018 and will cover the European Union across all 28 EU members. It’s a new legal framework in the EU that aims to protect citizens regarding the possession and usage of personal data. In the UK, the requirement to be compliant will be unaffected by the planned exit from the EU in 2019.

AccelStor Vice President, David Kao, said “With the GDPR coming into effect, it’s becoming crucial for any organisation and enterprise to review their internal process of handling any personal, company or government data. This calls for a refresh of security and data protection policies as well as new efficient tools and storage platforms like NeoSapphire all-flash array.”

As demand for high performance computing grows from the trend of IOT, artificial intelligence and big data analysis, enterprises require ever more powerful IT infrastructure. Different from conventional disk arrays, generating around 400K IOPS with over 1000 hard disk drives, the NeoSapphire all-flash array (AFA) could present stunning performance with a market-leading 1 million IOPS using only 24 SSDs and utilizing only 2U of rack space*. The NeoSapphire product range, using the FlexiRemap® software technology, coupled with a shared-nothing architecture, provides a proven AFA platform for data integrity and data protection. AccelStor’s NeoSapphire high availability all-flash array products deliver 99.9999% reliability and enable comprehensive data protection across the enterprise. Furthermore, to ensure minimum RPO and RTO for IT operators, the NeoSapphire series also provides instant failover, space-efficient snapshots, snapshots backup and a worry-free active-active hardware design.

Handling personal data is the key for GDPR compliance. Steps must be taken to minimise the risk of personal identification and ensure that the data inventory is stored in a secure location and device. The data controller must conduct privacy impact assessments and implement technical measures within the GDPR principles. As an enterprise storage vendor with customers who will be within the GDPR scope, AccelStor can provide Self Encrypting Disk (SED) SSDs which provide storage level data protection and compliance with the “data at rest” section of the GDPR regulation.

Additional Resources

Download the AccelStor GDPR Brochure
Learn more about the NeoSapphire all-flash array series
Learn more about FlexiRemap® Technology
Follow AccelStor on Twitter: @AccelStor
Follow AccelStor on Linkedin

About AccelStor, Inc.

AccelStor is accelerating the paradigm shift from conventional disk arrays to modern all-flash storage. AccelStor's NeoSapphire all-flash arrays, powered by FlexiRemap software technology, deliver sustained high IOPS for business-critical applications. With streamlined storage management, multi-protocol support, and front-access, hot-swappable solid-state drives, the NeoSapphire series promises to resolve performance bottlenecks for I/O-intensive applications like artificial intelligence, IoT, data center, virtualization, high-performance computing, database, media processing, fintech and gaming. For more information about AccelStor and NeoSapphire, please visit www.accelstor.com.

AccelStor, FlexiRemap and NeoSapphire are trademarks or registered trademarks of AccelStor, Inc. in the United States of America and/or other countries.

* IOPS test results mentioned in this press release are generated by AccelStor and may vary in different test environments.

Contact information

AccelStor, Inc.
Clara Lee, +886 2 77467616 ext. 2561
clara.lee@accelstor.com

Tietoja julkaisijasta

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Tilaa tiedotteet sähköpostiisi

Haluatko tietää asioista jo ennen kuin ne uutisoidaan? Kun tilaat tiedotteemme tältä julkaisijalta, saat ne sähköpostiisi yhtä aikaa suomalaisen median kanssa. Tilauksen voit halutessasi perua milloin tahansa.

Lue lisää julkaisijalta Business Wire

Ipsen and Exelixis announce phase 3 trial results of cabozantinib demonstrating significant overall survival benefit in patients with previously treated advanced hepatocellular carcinoma17.1.2018 01:05Tiedote

Regulatory News: Ipsen (Euronext:IPN; ADR:IPSEY) and Exelixis, Inc. (NASDAQ:EXEL) today announced detailed results of the pivotal phase 3 CELESTIAL trial in patients with previously treated advanced hepatocellular carcinoma (HCC), which will be presented in a late-breaking oral session at the 2018 ASCO-GI Symposium being held in San Francisco, January 18-20, 2018. In CELESTIAL, cabozantinib provided a statistically significant and clinically meaningful improvement versus placebo in overall survival (OS), the trial’s primary endpoint, at the planned second interim analysis (prespecified critical p value ≤ 0.021) for the population of second- and third-line patients enrolled in this study. Median OS was 10.2 months with cabozantinib versus 8.0 months with placebo (HR 0.76, 95 percent CI 0.63-0.92; p=0.0049). Median progression-free survival (PFS) was more than doubled, at 5.2 months with cabozantinib and 1.9 months with placebo (HR 0.44, 95 percent CI 0.36-0.52; p<0.0001). Objective resp

IFF to Release Fourth Quarter & Full Year 2017 Results February 1417.1.2018 00:15Tiedote

Regulatory News: International Flavors & Fragrances Inc. (NYSE:IFF) (Euronext Paris: IFF), a leading innovator of sensory experiences that move the world, announced that it will release its fourth quarter and full year 2017 earnings results following the market close on Wednesday, February 14, 2018. The management team will host a live webcast on Thursday, February 15, 2018 at 10:00 a.m. ET to discuss results and outlook with the investor community. Investors may access the live webcast and accompanying slide presentation on the Company's website at ir.iff.com. For those unable to listen to the live webcast, a recorded version will be made available for replay. Meet IFF International Flavors & Fragrances Inc. (NYSE:IFF) (Euronext Paris: IFF) is a leading innovator of sensorial experiences that move the world. At the heart of our company, we are fueled by a sense of discovery, constantly asking “what if?”. That passion for exploration drives us to co-create unique products that consumer

President Clinton to Address Healthcare Leaders Focused on Eliminating Preventable Deaths in Hospitals at the 6th Annual World Patient Safety, Science & Technology Summit16.1.2018 22:17Tiedote

For the 6th year in a row, President Bill Clinton, the Founder of the Clinton Foundation and 42nd President of the United States, will deliver keynote remarks at the 6th Annual World Patient Safety, Science and Technology Summit held in London, England, February 23-25, 2018. President Clinton, who serves as Honorary Chair of the Patient Safety Movement Foundation’s Regional Network Chairs, joins an acclaimed group of global leaders, government representatives, healthcare and hospital CEOs, medical experts and patient advocates who will gather for the first time in London to confront preventable hospital deaths around the world. This press release features multimedia. View the full release here: http://www.businesswire.com/news/home/20180116006614/en/ President Bill Clinton, the Founder of the Clinton Foundation and 42nd President of the United States, to speak at the 6th Annual World Patient Safety, Science & Technology Summit in London, England (Photo: Business Wire) “We are thrilled

Disaronno: The Mixing Star Makes a Step Change and Looks to Innovation16.1.2018 19:06Tiedote

After 10 years of competitions involving bartenders from different countries who were challenged to showcase the mixability of Disaronno, Disaronno’s contest The Mixing Star has changed direction. Convinced that trends today move on channels other than a performance in front of a jury, Disaronno, the most consumed Italian liqueur in the world and the brand embodying the coolest soul of Made in Italy, has transformed The Mixing Star to Innovation Hunter, a social media based "exploration" with a mission: identifying innovative trends in mixology and movers and shakers in the field, in the UK and around the world, filming and sharing them with the community of bartending experts. In London, Milan and Amsterdam Disaronno has selected a few bartenders who are revolutionizing the field. The ways in which they express innovation have been collected in a set of stylish short movies specially made by Disaronno. The protagonists are available on The Mixing Star Facebook page and YouTube channel

Christie’s Announces Public Preview Tour Dates for The Collection of Peggy and David Rockefeller16.1.2018 18:54Tiedote

Christie’s is pleased to confirm additional dates and locations for public preview exhibitions of the Collection of Peggy and David Rockefeller. Following the unveiling of early highlights in Hong Kong last November, Christie’s will now tour property to its flagship galleries in London (February 21 – March 8), Beijing (April 6 - 7), Los Angeles (April 6 – 12), and Shanghai (April 10 - 11), leading up to the auctions at Christie’s Rockefeller Center in New York in late spring. With each stop on the pre-sale tour, additional works of art and objects will be unveiled, revealing new facets of this storied, multi-category collection. The exhibitions, which are open to the public, are sponsored in partnership with private aviation company VistaJet. As a guide for collectors, Christie’s has launched a special issue of Christie’s Magazine dedicated to the Collection of Peggy and David Rockefeller. The issue re-acquaints readers with the Rockefeller family’s unique place in American history, an

Continuum Accelerates Global Expansion with Portland Europe16.1.2018 18:00Tiedote

Continuum ®, the exclusive provider of the only vertically integrated IT service delivery platform that enables MSPs to scale rapidly and profitably, today announced that it has signed a distribution agreement with Portland Europe, a leading distributor of scalable software solutions for the reseller channel throughout the Benelux region. The partnership will provide Portland Europe’s wide network of managed solution providers (MSPs) in the Benelux region with access to Continuum’s fully-managed remote monitoring and management (RMM) platform, powered by the company’s network operations center (NOC). Continuum’s platform has been proven to enable MSPs to efficiently manage thousands of customer endpoints, giving them back the resources to focus on higher-end, more profitable tasks at a time when skilled IT workers are highly sought-after. As opposed to having to correspond with multiple vendors, Portland Europe customers will benefit from having Continuum serve as a single point of con

Uutishuoneessa voit lukea tiedotteitamme ja muuta julkaisemaamme materiaalia. Löydät sieltä niin yhteyshenkilöidemme tiedot kuin vapaasti julkaistavissa olevia kuvia ja videoita. Uutishuoneessa voit nähdä myös sosiaalisen median sisältöjä. Kaikki STT Infossa julkaistu materiaali on vapaasti median käytettävissä.

Tutustu uutishuoneeseemme